Latest Profitability News

Plenti Group Limited has reported a record unaudited FY26 Cash Profit Before Tax of $30.8 million and a loan portfolio exceeding $3.1 billion, beating its original target months ahead of schedule. The fintech lender's growth was supported by strong loan originations, robust credit performance, and strategic technology investments.

StepChange Holdings delivered a robust $15.18 million in unaudited revenue and $1.46 million EBITDA in Q3 2026, driven by organic growth and the BroadReach acquisition. Margin improvements and AI integration highlight its evolving consulting model.

Rent.com.au has achieved a milestone with its first-ever positive operating cashflow of $0.5 million in Q3 FY26, alongside record quarterly revenue of $1.2 million and a 168% surge in recurring revenue.

Advanced Braking Technology Ltd (ASX: ABV) reported a 28% jump in product sales revenue to $6 million for Q3 FY26, driven by strong aftermarket sales and international market traction. The company also advanced certification of its autonomous BRAKEiQ system, targeting FY27 adoption.

Bank of Queensland’s statutory profit fell 20% to $136 million in 1H26, weighed down by a $31 million loss on its equipment finance portfolio sale. The bank advances its digital transformation and plans a $3.7 billion capital release with Challenger Limited, maintaining strong capital and dividend guidance.

South32's March quarter saw a tragic fatality at Worsley Alumina and weather disruptions, yet the miner delivered solid operational results and progressed its Hermosa zinc-lead-silver project. Production guidance was mostly maintained, with a notable revision lower for Australia Manganese due to water management issues.

Energy Action Limited posted a milestone quarter ending March 2026, delivering positive operating cash flow for the first time in FY26 alongside strong revenue gains and a notable $0.5 million debt repayment. Governance changes add a layer of uncertainty ahead of a scheduled general meeting.

Metro Mining Limited (ASX:MMI) is set to reduce its share count drastically through a 20-for-1 consolidation, pending shareholder approval at the upcoming AGM. This move will slash its ordinary shares from over 6 billion to just over 300 million, reshaping its capital structure.

Elixinol Wellness maintained steady revenue at $3.5 million in Q1 FY26 while boosting gross margins to 45% and reporting a second consecutive quarter of positive underlying operating cash flow.

The L1 Global Long Short Fund (ASX:GLS) faced a challenging March quarter amid the Iran War-driven oil supply shock but maintains strong performance since inception through active portfolio adjustments and thematic focus on copper, gold, and infrastructure.

Mineral Resources has priced a US$1.3 billion senior unsecured notes offering to refinance higher-cost debt, reduce annual finance expenses by $48 million, and extend its weighted average debt maturity from 3.1 to 5 years.

Starpharma has secured FDA alignment on the clinical development plan for its DEP® HER2 radiotherapy candidate, paving the way for a first-in-human phase 1 study in advanced HER2-positive cancers scheduled for H2 2026.